Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,650
datasets available to search
ShareScore release 0.9.0
Dataset results
3,650 results for “antibody”
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
ClinicalTrials.gov study NCT02777710. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors
ClinicalTrials.gov study NCT04172506. IPD Sharing: NO. Countries: 1. Publications: 2.
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC
ClinicalTrials.gov study NCT06206096. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
ClinicalTrials.gov study NCT01485003. IPD Sharing: Not stated. Countries: 1. Publications: 5.
BIOmarkers of MIGraine: a Proof of Concept Study Based on the Stratification of Responders to CGRP Monoclonal Antibodies
ClinicalTrials.gov study NCT04503083. IPD Sharing: NO. Countries: 3. Publications: 17.
JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects
ClinicalTrials.gov study NCT04780321. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)
ClinicalTrials.gov study NCT04567810. IPD Sharing: NO. Countries: 1. Publications: 2.
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab
ClinicalTrials.gov study NCT00605943. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis
ClinicalTrials.gov study NCT06762080. IPD Sharing: NO. Countries: 1. Publications: 2.
Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment
ClinicalTrials.gov study NCT04779996. IPD Sharing: NO. Countries: 1. Publications: 3.
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
ClinicalTrials.gov study NCT03470311. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies
ClinicalTrials.gov study NCT05206045. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
ClinicalTrials.gov study NCT01202695. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT03410901. IPD Sharing: NO. Countries: 1. Publications: 2.
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
ClinicalTrials.gov study NCT05385432. IPD Sharing: Not stated. Countries: 0. Publications: 2.
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
ClinicalTrials.gov study NCT04966884. IPD Sharing: NO. Countries: 1. Publications: 4.
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age
ClinicalTrials.gov study NCT02610348. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
ClinicalTrials.gov study NCT04531787. IPD Sharing: NO. Countries: 1. Publications: 1.
The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy
ClinicalTrials.gov study NCT07040813. IPD Sharing: UNDECIDED. Countries: 1. Publications: 35.
Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05701553. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.